Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.820
+0.040 (1.44%)
At close: Apr 10, 2026, 4:00 PM EDT
2.880
+0.060 (2.13%)
After-hours: Apr 10, 2026, 7:52 PM EDT

CNTB Stock Forecast

Stock Price Forecast

The 3 analysts that cover CNTB stock have a consensus rating of "Strong Buy" and an average price target of $8.67, which forecasts a 207.45% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $10.

Price Target: $8.67 (+207.45%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$7.00$8.67$9.00$10
Change+148.23%+207.45%+219.15%+254.61%

Analyst Ratings

The average analyst rating for CNTB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingNov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy344443
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total344443

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
BTIG
BTIG
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+254.61%Apr 1, 2026
BTIG
BTIG
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+254.61%Mar 31, 2026
Lake Street
Lake Street
Strong Buy
Initiates
$9
Strong BuyInitiates$9+219.15%Dec 1, 2025
BTIG
BTIG
Strong Buy
Reiterates
$10
Strong BuyReiterates$10+254.61%Nov 13, 2025
BTIG
BTIG
Strong Buy
Initiates
$10
Strong BuyInitiates$10+254.61%Oct 31, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
5.10M
from 64.00K
Increased by 7,868.75%
Revenue Next Year
78.24M
from 5.10M
Increased by 1,434.16%
EPS This Year
-4.18
from -1.00
EPS Next Year
-3.64
from -4.18
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJan 1, 2022Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
---26.03M64.00K5.10M78.24M
Revenue Growth
-----99.75%7,868.75%1,434.16%
EPS
-3.88-2.15-1.13-0.28-1.00-4.18-3.64
EPS Growth
-------
Forward PE
-------
No. Analysts
-----77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
High15.8M301.2M
Avg5.1M78.2M
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High
24,509.4%
5,805.3%
Avg
7,868.8%
1,434.2%
Low--

EPS Forecast

EPS202620272028
High-0.89-0.79
Avg-4.18-3.64
Low-7.18-6.76

EPS Growth

EPS Growth202620272028
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.